Gastrimmune blocker of the hormone gastrin 17: APHT began Phase III testing

Aphton Corp. (APHT), Woodland, Calif. Product: Gastrimmune blocker of the hormone gastrin 17 Indication: Gastrointestinal cancer Status: APHT began Phase III testing in 760 patients with stage II and ...